Risk-sharing Agreements for Medical Devices in Emerging Markets: Opportunities and ChallengesRisk-Sharing Agreements • June 25th, 2015
Written by Ridhima Aggarwal, The Salmon and Rameau Research Programme Manager with the Healthcare Management Initiative at INSEAD and Shruti Veenam, INSEAD MBA’14J.
The experience in CataloniaRisk Sharing Agreements • June 6th, 2019
• Responsible for healthcare resource allocation and budget planning, healthcare service planning, health technology assessment
Risk Sharing Agreements in KoreaRisk Sharing Agreements • June 6th, 2019
ABSTRACTRisk-Sharing Agreements • August 31st, 2013
HPR175Risk-Sharing Agreements • November 4th, 2024
around long-term treatment outcomes and the cost-effectiveness of gene therapies. Outcome-based agreements offer the opportunity to link payment for treatment to the benefits received by the patient
NEW RISK-SHARING AGREEMENTS FOR PHARMA INDUSTRY - ROCA JUNYENTRisk-Sharing Agreements • October 11th, 2022
The scheme is designed according to a system of payment/reimbursement that is directly related to the effectiveness of the medicament and/or its cost-effectiveness. The scheme will be referred to by different names, such as risk-sharing agreements (RSA), patient access schemes (PAS), performance-based agreements (PBA) and managed entry agreements (MEA).
Risk Sharing Agreements for Health Technology Assessment Experience in TaiwanRisk Sharing Agreements • June 6th, 2019
